Could a common supplement help alcoholic cirrhosis patients live longer?

NCT ID NCT04250259

First seen Nov 01, 2025 · Last updated May 09, 2026 · Updated 23 times

Summary

This study tests whether a supplement called SAMe can improve liver function and reduce the risk of death in people with alcoholic cirrhosis. About 196 adults with mild to moderate cirrhosis will receive either SAMe or a placebo for a period of time. The goal is to see if SAMe helps the liver work better and lowers the chance of dying from the disease.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ALCOHOLIC CIRRHOSIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Cedars-Sinai Medical Center

    RECRUITING

    Los Angeles, California, 90048, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

  • Indiana University Hospital

    RECRUITING

    Indianapolis, Indiana, 46202, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

Conditions

Explore the condition pages connected to this study.